首页> 外文期刊>Minimally invasive neurosurgery: MIN >Risk factors for regrowth of intracranial meningiomas after gamma knife radiosurgery: importance of the histopathological grade and MIB-1 index.
【24h】

Risk factors for regrowth of intracranial meningiomas after gamma knife radiosurgery: importance of the histopathological grade and MIB-1 index.

机译:伽玛刀放射外科手术后颅内脑膜瘤再生的危险因素:组织病理学等级和MIB-1指数的重要性。

获取原文
获取原文并翻译 | 示例
           

摘要

INTRODUCTION: The influence of histopathological grade and MIB-1 index of intracranial meningioma on the results of its radiosurgical management is not clear. The objective of the present retrospective study was to make an evaluation of these factors along with an analysis of other variables associated with progression-free survival after gamma knife radiosurgery (GKR). PATIENTS AND METHODS: Thirty-four intracranial meningiomas with known detailed histopathological diagnosis were analyzed. Tumors of WHO histopathological grades I, II, and III were diagnosed in 24, 3, and 7 cases, respectively. The median MIB-1 index was 1.3% (range: 0-31.9%). In 14 cases the MIB-1 index was 3.0% and more. In 26 cases the treatment was done at the time of tumor recurrence. Median volume of the neoplasm at the time of GKR was 4.1 mL (range: 0.4-43.1 mL). Median marginal dose was 12 Gy (range: 8-19 Gy). Median length of follow-up constituted 63 months (range: 19-132 months). RESULTS: Actuarial progression-free survival at 1, 3, 5, and 10 years constituted 100, 94, 83, and 58%, respectively. Histopathological grade II or III (p<0.0001), MIB-1 index 3% and more (p=0.0004), and non-skull base location (p=0.0026) of the tumor showed negative associations with progression-free survival in multivariate analyses. Actuarial progression-free survival at 5 years after GKR for benign and non-benign meningiomas constituted 100 and 45%, respectively (p<0.0001). CONCLUSION: Radiosurgery is a highly effective management option for benign intracranial meningiomas, but growth control of non-benign ones is significantly worse. It requires close neuroradiological follow-up and necessitates the search for modified treatment strategies.
机译:引言:颅内脑膜瘤的组织病理学分级和MIB-1指数对其放射外科治疗结果的影响尚不清楚。本回顾性研究的目的是对这些因素进行评估,并对与伽玛刀放射手术(GKR)后无进展生存相关的其他变量进行分析。病人与方法:分析了34例已知详细的组织病理学诊断的颅内脑膜瘤。分别诊断出24、3和7例WHO组织病理学I,II和III级肿瘤。 MIB-1指数中位数为1.3%(范围:0-31.9%)。在14例中,MIB-1指数为3.0%或更高。在26例中,在肿瘤复发时进行了治疗。 GKR时肿瘤的中位体积为4.1 mL(范围:0.4-43.1 mL)。中位边缘剂量为12 Gy(范围:8-19 Gy)。中位随访时间为63个月(范围:19-132个月)。结果:1、3、5和10年的无精算无进展生存率分别占100%,94%,83%和58%。在多变量分析中,肿瘤的组织病理学II级或III级(p <0.0001),MIB-1指数≥3%(p = 0.0004)和非颅底位置(p = 0.0026)与无进展生存率呈负相关。 GKR后良性和非良性脑膜瘤的5年无精算无进展生存率分别为100%和45%(p <0.0001)。结论:放射外科手术是良性颅内脑膜瘤的一种高效治疗方法,但非良性脑膜瘤的生长控制明显较差。它需要密切的神经放射学随访,因此有必要寻找改良的治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号